Novartis AG Increase Decrease Through Business Combinations Deferred Tax Liability Asset
Novartis AG (NVSEF) reported Increase Decrease Through Business Combinations Deferred Tax Liability Asset of $334.00 million for the 12-month period ending 2024-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset · last filed 2026-02-04
| Period end | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month |
|---|---|
| 2024-12-31 | $334.00M 20-F · filed 2026-02-04 |
| 2022-12-31 | $244.00M 20-F · filed 2024-01-31 |
| 2021-12-31 | $46.00M 20-F/A · filed 2023-05-15 |
| 2020-12-31 | $1.50B 20-F · filed 2022-02-02 |
| 2019-12-31 | $47.00M 20-F · filed 2021-01-26 |
| 2018-12-31 | $2.49B 20-F · filed 2020-01-29 |
| 2017-12-31 | -$317.00M 20-F · filed 2019-01-30 |
| 2016-12-31 | -$336.00M 6-K · filed 2018-01-24 |